Last reviewed · How we verify
NCT03542318
Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis
trial testing Pulmonary Rehabilitation in Pulmonary Fibrosis in 120 participants. Completed in 31 January 2016.
31 January 2016
Quick facts
| Lead sponsor | University of Malta |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 March 2014 |
| Primary completion | 31 January 2016 |
| Estimated completion | 31 January 2016 |
| Sites | 1 location across Malta |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Pulmonary Fibrosis — all drugs for Pulmonary Fibrosis →
Sponsor
University of Malta
Who can join
30 and older, any sex, with Pulmonary Fibrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The inclusion of Pulmonary Rehabilitation (PR) as part of the management of pulmonary fibrosis although being highly recommended and recommended in guidelines still sees studies exploring the outcomes from such an intervention limited. The present study aims to contribute to the available literature by investigating the effects of a high intensity, 12week PR programme on functional and quality of life measures in patients with a diagnosis of pulmonary fibrosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi V, Chaudhuri N, Torrisi SE, Kahn N, et al · · 2019 · cited 183× · PMID 31484664 · DOI 10.1183/16000617.0021-2019
Verify or expand the search:
- PubMed search for NCT03542318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Pulmonary Fibrosis
Currently open trials in the same condition.
- NCT07464132 — Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases · Phase 1, PHASE2 · recruiting
- NCT07396467 — Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis · active not recruiting
- NCT06912659 — The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis W · active not recruiting
- NCT06685874 — Interstitial Lung Disease Exacerbations Study · active not recruiting
- NCT06532071 — Advanced Imaging for Pulmonary Fibrosis · Phase 2 · recruiting
Other University of Malta trials
Trials by the same sponsor.
- NCT06898827 — Distraction Therapy Using Virtual Reality in Cardiac Rehabilitation · NA · enrolling by invitation
- NCT06774066 — High Volume Injection in Mid Portion AChilles Tendinopathy · NA · completed
- NCT05920096 — Feasibility of a Diabetes Specialist Nurse-led Smoking Cessation Intervention · NA · completed
- NCT04771936 — Relationship of Core Stability on Pain and Functional Levels in Patients Diagnosed With Hip Osteoarthritis · NA · completed
- NCT04775433 — 'The Actual and Perceived Levels of Physical Fitness and Lifestyle Habits in University of Malta Students' · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03542318 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Malta
- Last refreshed: 6 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03542318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing